1.Analysis of the ethical dilemmas of patients in a cancer specialty hospital in the context of the smart hospital
Chinese Medical Ethics 2025;38(2):261-266
ObjectiveTo explore the ethical dilemmas of patients in a cancer specialty hospital in the context of the smart hospital and to propose relevant countermeasures. MethodsUsing the purposive sampling method, medical staff from a tertiary cancer specialty hospital in a certain city were selected as research subjects from December 2023 to January 2024. Qualitative interviews were conducted on the ethical dilemmas of the specialized cancer patients in the context of the smart hospital, and Nvivo 12.0 software was used for data transcription and analysis. ResultsThree themes were extracted. First, the ethical dilemmas faced by specialized cancer patients in the context of smart hospitals, including the ethical dilemma between privacy protection and information disclosure, the right to life and choice, fairness and priority, and scientific research and clinical practice. Second, smart hospitals relied on advanced information technology to improve the level of medical teaching and research, but this had led to various ethical dilemmas mentioned above. Medical staff should correctly view and scientifically respond to these ethical dilemmas. Third, the response strategies for ethical dilemmas in cancer specialty hospitals in the context of smart hospitals include improving relevant policies and regulations, optimizing medical resource allocation, strengthening ethics education of medical staff, enhancing doctor-patient communication, and strengthening feedback and regulatory mechanisms. ConclusionMedical institutions should strengthen ethical supervision while promoting innovation and application of medical information technology, to ensure compliance and sustainability in the development of smart hospitals.
2.Research progress on the construction of quality indicators for evaluating the psychiatric nursing care based on Donabedian model
Lanlan CHEN ; Qiaoling LIAO ; Huan WANG ; Chunlan BAI ; Yali WANG
Sichuan Mental Health 2022;35(6):580-584
This article aims to provide a review of the domestic and foreign studies on the quality indicators for evaluating the psychiatric nursing care in recent years. According to Donabedian model, the research progress of quality indicators for evaluating the psychiatric nursing care were described from the three dimensions of structure quality, process quality and outcome quality. This paper summarizes the status of the research, points out the shortcomings of existing research, and provides references for the future research on the quality indicators for evaluating the psychiatric nursing care.
3.Advancement on the pharmacogenomics of immunosuppressant
Yun LIAO ; Yi LI ; Bei CAI ; Lanlan WANG
Chinese Journal of Laboratory Medicine 2012;(11):978-985
At present,transplantation has been the predominant way to solve most of the end-stage diseases,ensued by the use of immunosuppressive drugs.Since the immunosuppressive drugs have narrow therapeutic index,the blood drug concentration is needed to mornior.Pharmacogenetics is one subject which focuses on the interaction between gene and the metabolism of the drug,providing great help for designing the regime of achieving the target drug concentration.Meanwhile,it facilitates the realization of individual therapy.This review thus focuses on the latest advancement on the pharmacogenetics of those immunosupprressants,hoping to provide help for the treatment.
4.Diagnostic role of Golgi protein 73 and its gene determination in primary hepatic carcinoma
Yuling SHI ; Lanlan ZENG ; Linhai LI ; Zhaohui SUN ; Yang LIAO ; Jianyun CHEN
Chinese Journal of Laboratory Medicine 2010;33(6):507-512
Objective To explore the diagnostic value of GP-/3 protein in gene detection in the patient of primary hepatic carcinoma, to discuss the joint roles of serum GP73 and AFP, and provide a novel method for the diagnosis for PHC and screening for high-risk population. Methods ELISA was used to detect the serum level of GP73 and AFP in 73 cases of PHC, 13 cases of hepatic cirrhosis, 32 cases of hepatitis and 62 cases of health people. SYBR Green real time fluorescence quantitative PCR was used to detect the relative value of GP73 mRNA in the peripheral blood cells of each group. Comparative Ct method was used to evaluate the relative expression levels. Eight cases of normal liver tissues and 8 cases of PHC tissues were detected at the same time to compare the relative expression levels. Results Kruskal-Wallis test showed that the serum levels of GP73 and AFP had significant differences between four groups(H value were 89. 6 and 52.0, P < 0. 01) and the whole blood GP73 mRNA had no significant differences(H =4. 33, P > 0. 05). Mann-Whitney test showed that the serum levels of GP73 had significant differences among PHC groups[166. 7 (162. 7-231.8) μg/L] and liver cirrhosis[57. 3 (46. 6-113. 6) μg/L], hepatitis[29. 6(26. 2-54. 5) μg/L], health group[25.1 (20. 8-29. 4) μg/L] (U value were 246, 297, 349, P < 0. 01).The A FP levels of the four groups were 380. 9 (258.5-503.2) μg/L, 3.8 (1.3-14. 5) μg/L, 5. 1 (2. 4-7. 8)μg/L and 2. 8(2. 2-5.7) μg/L. It also showed significant differences (U value were 246,419 and 790,P <0. 01). The GP73 mRNA expression of PHC liver tissues(12. 64) was significant higher than normal liver tissues (1.00). The critical values for GP73 and AFP was determined to be 123. 2 μg/L and 10. 6 μg/L through the 8OC curves. Under the critical value the sensitivity of GP73 and AFP were 65.8% and 53.4% ,and the specificity of CP73 and AFP were 95.3% and 92. 5% respectively. Joint detection could increase the sensitivity up to 79. 5%, and achieve the high specificity of 90. 7%. Conclusions As a new diagnositic marker of primary hepatic carcinoma, GP73 protein has the very good sensitivity and specificity. The GP73 mRNA in the whole blood sample could not be used for the diagnosis of PHC. But it woule be a good molecular marker for diagnosis of PHC in the liver tissue sample. The joint detection of GP73 and AFP could improve PHC diagnostic performance, and provide an effective approcach to the PHC high-risk screening.
5.Application of Procalcitonin Test in Lower Respiratory Tract Infection
Yuling SHI ; Yang LIAO ; Zhu ZHEN ; Lanlan ZENG
Chinese Journal of Nosocomiology 1994;0(01):-
OBJECTIVE To evaluate the diagnosis value of the procalcitonin(PCT) test in the lower respiratory tract infection(LRTI),and to provide the application of PCT in the bacterial infectious disease.METHODS Procalcitonin concentrations were measured using the quantitative immunofluorescence test in 93 patients and the results were compared with the levels of C-reactive protein(CRP) and white blood cell count(WBC).Samples were collected and divided into 2 groups,one including 63 cases(bacterial infected group) the other including 30 cases(non-bacterial infected group) corresponding to their clinical diagnosis(temperature,heart rate,bacteremia culture,CRP,WBC count).RESULTS The levels of PCT in bacterial infected group were significantly higher than in non-bacterial infected group(P

Result Analysis
Print
Save
E-mail